Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Upgrades aim to improve asthma relief and COPD treatment with advanced technology.United States, January 31, 2025 -- TruNeb ...

A graduate of Stanford University’s prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

We've all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

“Patients with mild-to-moderate COPD who have low exercise tolerance are likely to experience poor respiratory health outcomes,” the investigators concluded. “Exercise tolerance may be considered one ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Share on Pinterest PongMoji/Getty Images Spirometry is an important tool for diagnosing and determining treatment for chronic obstructive pulmonary disease (COPD). This breathing test can detect ...

UK pharma major AstraZeneca’s (LSE: AZN) Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 JP Morgan Healthcare Conference, is set to transform the chronic ...